Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Practical Implications for Treatment Strategies in Advanced Ovarian Cancer
EP. 1: An Introduction to the Discussion of Ovarian Cancer
July 20th 2020
EP. 2: Biomarker-Driven Frontline Ovarian Cancer Treatment
July 20th 2020
EP. 3: The Impact of PAOLA-1 on Frontline Treatment of Ovarian Cancer
July 20th 2020
EP. 4: Impact of HRD Status on Frontline Treatment of Ovarian Cancer
July 20th 2020
EP. 5: Need for Frontline Comparison Trials in Ovarian Cancer
July 20th 2020
EP. 6: Treating BRCA+ Ovarian Cancer
July 20th 2020
EP. 7: Treating Homologous Recombination Proficient Ovarian Cancer
July 20th 2020
EP. 8: Personalized Dosing of Niraparib in Ovarian Cancer
July 20th 2020
EP. 9: NCCN Guidelines and FDA Approvals for Treating Ovarian Cancer
July 20th 2020
EP. 10: PAOLA-1 Study Surgical Subset for Ovarian Cancer
July 20th 2020
EP. 11: Patient Preference for Treatment in Ovarian Cancer
July 20th 2020
EP. 12: Emerging Combinations in the Frontline Setting of Ovarian Cancer
July 20th 2020
EP. 13: Expert Approaches for Treating Recurrent Ovarian Cancer
July 20th 2020
EP. 14: PARP Inhibitors in Recurrent Ovarian Cancer
July 20th 2020
EP. 15: New Data for Secondary Surgery in Ovarian Cancer
July 20th 2020
EP. 16: Neoadjuvant Therapy Versus Surgery for Ovarian Cancer
July 20th 2020
EP. 17: Antibody Drug Conjugates for Ovarian Cancer
July 20th 2020
EP. 18: Emerging Therapies in Recurrent Ovarian Cancer
July 20th 2020
EP. 19: Upcoming Clinical Trials for Ovarian Cancer
July 20th 2020